Description

This blend combines CJC-1295 without DAC (12mg) and ipamorelin (6mg) in one vial. The two peptides act on different receptors that both lead to growth hormone release, which is why they are one of the most studied pairings in GH-axis research.

What is in the CJC-1295 / Ipamorelin Blend?

CJC-1295 without DAC (modified GRF 1-29): a 29-amino-acid GHRH analogue with four amino acid substitutions that improve stability. It acts on the GHRH receptor.
Ipamorelin: a pentapeptide agonist of the ghrelin receptor (GHS-R1a). In animal studies it released GH with little effect on cortisol or prolactin.

Researchers pair a GHRH analogue with a ghrelin-receptor agonist because the two pathways amplify each other in pituitary models.

Research Applications

Pulsatile GH secretion and GH/IGF-1 signalling
GHRH and GHS-R1a receptor interaction
Body-composition and muscle-protein models
Age-related decline in GH output

Product Specifications

Available sizes: 12mg CJC-1295 no DAC / 6mg ipamorelin blend
Form: lyophilized powder in a sealed vial
Purity: ≥99% (HPLC), manufactured in the USA
Certificate of Analysis available for each batch
Storage: store lyophilized product at -20°C, protected from light

For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic. Sold to qualified researchers for in-vitro and laboratory research.